Effect of the Ouji (Menta aquatica) product on bloating
Phase 3
- Conditions
- bloating.Abdominal distension (gaseous) Bloating Eructation Gas pain Tympanists (abdominal)(intestinal)
- Registration Number
- IRCT20190425043371N1
- Lead Sponsor
- Sari University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
All patient with bloating in basis of IBS 20 - 80
Exclusion Criteria
diabet?heart? liver? kidney failure?asthma?COPD?neoplasm?sever mental disorder
Pregnant women, Women who intend to get pregnant and lactating women
Patients who have had gastric or intestinal surgery
History of receiving drugs to eradicate Helicobacter pylori in the last three months
Alcohol or opioid adiction
People with history of lactase deficiency
Patients who use a cardiovascular medicine, antihypertensive drug, anticoagulants, anxiolytics or steroids.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Intensity of bloating. Timepoint: Measure the severity of bloating before starting the study.14 and 28 days after taking Ouji And 14 days after the study. Method of measurement: visual analog scale.
- Secondary Outcome Measures
Name Time Method